Vicarious Surgical (RBOT) EBIT (2020 - 2025)

Vicarious Surgical (RBOT) has 6 years of EBIT data on file, last reported at -$11.5 million in Q3 2025.

• On a quarterly basis, EBIT rose 35.21% year-over-year to -$11.5 million in Q3 2025; TTM through Sep 2025 was -$55.7 million, a 16.94% increase from a year earlier, with the FY2024 full-year figure at -$66.6 million, up 17.49% from the prior year.
• EBIT for Q3 2025 stood at -$11.5 million, up from -$13.5 million in the prior quarter.
• Over the last five years, EBIT for RBOT reached as high as -$5.2 million in Q1 2021 and fell as low as -$22.3 million in Q1 2023.
• Historically, EBIT has averaged -$16.1 million across 5 years, with a median of -$17.7 million in 2024.
• Across the five-year window, EBIT tumbled 24660.34% in 2021 and soared 35.21% in 2025, its largest moves.
• Year by year, EBIT stood at -$17.8 million in 2021, then declined by 15.66% to -$20.6 million in 2022, then climbed by 24.59% to -$15.5 million in 2023, then rose by 3.62% to -$15.0 million in 2024, then rose by 23.2% to -$11.5 million in 2025.
• Per Business Quant data, the three most recent EBIT figures were -$11.5 million in Q3 2025, -$13.5 million in Q2 2025, and -$15.7 million in Q1 2025.